Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial

Title
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial
Authors
Keywords
metastatic colorectal cancer, biomarker, miR-31-3p, anti-EGFR, cetuximab
Journal
Oncotarget
Volume -, Issue -, Pages -
Publisher
Impact Journals, LLC
Online
2017-09-28
DOI
10.18632/oncotarget.21291

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search